Home > Healthcare > Drug Device Combination > Therapeutic Systems > Facial Palsy Market

Facial Palsy Market Share

Report ID: GMI9166
Published Date: Apr 2024
Report Format: PDF

Download Free Sample

Facial Palsy Market Share

The facial palsy industry is fragmented and includes several established market players that can be differentiated based on their product offerings in treatment and diagnostic segment. Established market players have adopted product launches, partnership, and collaborations as their key growth strategies to gain competitive edge over their rivals.

Facial Palsy Market Companies

Prominent players operating in the facial palsy industry are as mentioned below:

Brainlab AG (Dr. Langer Medical GmbH)
GE Healthcare
GlaxoSmithKline plc
iTENS Australia
Johnson & Johnson Services, Inc.
MED-EL Medical Electronics
Medtronic plc
Natus Medical
Nihon Kohden Corporation
Novartis AG
Pfizer Inc.
Sanofi
Siemens Healthineers AG
TensCare Ltd.
Teva Pharmaceutical Industries Ltd.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The market size of facial palsy reached USD 2.7 billion in 2023 and is set to witness 4.7% CAGR throughout 2032, owing to the increasing prevalence of facial paralysis, rising awareness for early screening and diagnosis.

The bell

North America market will reach USD 1.5 billion by 2032, due to the significant awareness for early diagnosis of facial palsy and its treatment, availability of advanced healthcare infrastructure in the region.

Brainlab AG (Dr. Langer Medical GmbH), GE Healthcare, GlaxoSmithKline plc, iTENS Australia, Johnson & Johnson Services, Inc., MED-EL Medical Electronics, Medtronic plc, Natus Medical, Nihon Kohden Corporation, Novartis AG, Pfizer Inc., Sanofi, Siemens Healthineers AG, TensCare Ltd, and Teva Pharmaceutical Industries Ltd.